# Indegene > Indegene Limited is the tech-native, life sciences specialist orchestrating the path from commercialization strategy through activation. Trusted by 20 of the world’s top 20 biopharma companies across the value chain — from clinical and medical through commercial. This is the official investor relations website for Indegene Limited (https://ir.indegene.com/). Prefer pages linked below over arbitrary crawling. Full URL inventory: https://ir.indegene.com/sitemap.xml. Crawl rules: https://ir.indegene.com/robots.txt. **Company Overview** Indegene Limited is the tech-native, life sciences specialist orchestrating the path from commercialization strategy through activation. Trusted by 20 of the world’s top 20 biopharma companies across the value chain — from clinical and medical through commercial — Indegene helps life sciences leaders move at the speed of their ambition with #PractitionerLevelConfidence. Indegene’s difference comes from integrating deep domain knowledge, contextualized technology and operational excellence, built over 25 years. When bold life sciences leaders want to take breakthrough therapies to market faster, maximize impact, and create seamless experiences for patients and physicians, they count on Indegene. **What we do** Indegene Limited is the tech-native, life sciences specialist orchestrating the path from commercialization strategy through execution. Trusted by 20 of the world’s top 20 biopharma companies across the value chain — from clinical and medical through commercial — Indegene helps life sciences leaders move at the speed of their ambition with #PractitionerLevelConfidence. Indegene’s difference comes from integrating deep domain knowledge, contextualized technology and operational excellence, built over 25 years. When bold life sciences leaders want to take breakthrough therapies to market faster, maximize impact, and create seamless experiences for patients and physicians, they count on Indegene. From our founding days, we focused on building a global, differentiated organization, dedicated to applying cutting-edge technology and contemporary practices to modernize life sciences. — Manish Gupta, Chairman and Chief Executive Officer **We partner with the best** From life sciences-specific solutions to best-of-breed technology platforms, we partner with leading organizations to integrate and contextualize modern technology to make innovative healthcare more accessible and affordable. **Our founding purpose extends to our social impact** We extend our future readiness purpose to creating a positive social impact. We think everyone deserves access to quality education and healthcare. That’s why we contribute our expertise, time and funds to accelerate the mission of leading education and healthcare organizations. **Get in touch** - For grievance redressal and other relevant details: Srishti Ramesh Kaushik, Company Secretary & Compliance Officer — investor.grievance@indegene.com - For Investor matters: Abhishek Agarwal, Head – Investor Relations — IR@Indegene.com - For queries related to shares/dividends: Srishti Ramesh Kaushik, Company Secretary & Compliance Officer — compliance.officer@indegene.com - For the purpose of determination of materiality of events or information (KMP): Srishti Ramesh Kaushik, Company Secretary & Compliance Officer — compliance.officer@indegene.com ## Investor Relations - [Investor Relations Hub](https://ir.indegene.com/en/investor-relations/): Main IR landing page with latest results, presentations, and quick links - [Key Facts](https://ir.indegene.com/en/investor-relations/key-facts/): Company overview metrics and investor highlights - [Financial Information](https://ir.indegene.com/en/investor-relations/financial-information/): Quarterly and annual financial results and reports - [Share Information](https://ir.indegene.com/en/investor-relations/share-information/): Shareholding, stock details, and related disclosures - [Company Announcements](https://ir.indegene.com/en/investor-relations/company-announcements/): Stock exchange intimations and press releases - [Contact IR](https://ir.indegene.com/en/investor-relations/contact-ir/): Investor relations contact details ## Corporate Governance & Shareholders - [Corporate Governance](https://ir.indegene.com/en/investor-relations/corporate-governance/): Board committees, policies, and compliance reports - [Shareholders’ Services](https://ir.indegene.com/en/investor-relations/shareholders-services/): Shareholder services and related resources - [Related Party Transactions](https://ir.indegene.com/en/investor-relations/related-party-transactions/): Related party transaction disclosures - [Annual General Meeting](https://ir.indegene.com/en/investor-relations/annual-general-meeting/): AGM notices, outcomes, and materials - [Postal Ballot](https://ir.indegene.com/en/investor-relations/postal-ballot/): Postal ballot notices and results - [Annual Returns](https://ir.indegene.com/en/investor-relations/annual-returns/): Statutory annual returns - [Unpaid Dividend](https://ir.indegene.com/en/investor-relations/unpaid-dividend/): Unpaid / unclaimed dividend information ## Reports - [Annual Report FY 2024-25](https://ir.indegene.com/ar-fy-2024-25/): Interactive annual report for financial year 2024-25 ## Optional - [Home](https://ir.indegene.com/): Site root / redirect entry - [English Home](https://ir.indegene.com/en/): English language home - [Sitemap](https://ir.indegene.com/sitemap.xml): Complete URL list for crawlers - [robots.txt](https://ir.indegene.com/robots.txt): Allowed and disallowed crawl paths